201 related articles for article (PubMed ID: 22170068)
21. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.
Park B; Brinkmann MM; Spooner E; Lee CC; Kim YM; Ploegh HL
Nat Immunol; 2008 Dec; 9(12):1407-14. PubMed ID: 18931679
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 9-mediated inhibition of apoptosis occurs through suppression of FoxO3a activity and induction of FLIP expression.
Lim EJ; Park DW; Lee JG; Lee CH; Bae YS; Hwang YC; Jeong JW; Chin BR; Baek SH
Exp Mol Med; 2010 Oct; 42(10):712-20. PubMed ID: 20739833
[TBL] [Abstract][Full Text] [Related]
23. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase.
Amcheslavsky A; Bar-Shavit Z
J Bone Miner Res; 2007 Aug; 22(8):1301-10. PubMed ID: 17488193
[TBL] [Abstract][Full Text] [Related]
26. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
27. Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9.
Zhang Y; Lin A; Zhang C; Tian Z; Zhang J
Cancer Immunol Immunother; 2014 Apr; 63(4):357-67. PubMed ID: 24452201
[TBL] [Abstract][Full Text] [Related]
28. DNA motifs suppressing TLR9 responses.
Trieu A; Roberts TL; Dunn JA; Sweet MJ; Stacey KJ
Crit Rev Immunol; 2006; 26(6):527-44. PubMed ID: 17341193
[TBL] [Abstract][Full Text] [Related]
29. ARF6 activated by the LHCG receptor through the cytohesin family of guanine nucleotide exchange factors mediates the receptor internalization and signaling.
Kanamarlapudi V; Thompson A; Kelly E; López Bernal A
J Biol Chem; 2012 Jun; 287(24):20443-55. PubMed ID: 22523074
[TBL] [Abstract][Full Text] [Related]
30. The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage.
Zhang X; Gao M; Ha T; Kalbfleisch JH; Williams DL; Li C; Kao RL
Shock; 2012 Aug; 38(2):146-52. PubMed ID: 22576005
[TBL] [Abstract][Full Text] [Related]
31. The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma.
Pradhan P; Qin H; Leleux JA; Gwak D; Sakamaki I; Kwak LW; Roy K
Biomaterials; 2014 Jul; 35(21):5491-504. PubMed ID: 24720881
[TBL] [Abstract][Full Text] [Related]
32. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
33. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.
Chinnery HR; McLenachan S; Binz N; Sun Y; Forrester JV; Degli-Esposti MA; Pearlman E; McMenamin PG
Am J Pathol; 2012 Jan; 180(1):209-20. PubMed ID: 22085974
[TBL] [Abstract][Full Text] [Related]
34. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
[TBL] [Abstract][Full Text] [Related]
35. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
Assaf A; Esteves H; Curnow SJ; Browning MJ
Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
[TBL] [Abstract][Full Text] [Related]
36. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
[TBL] [Abstract][Full Text] [Related]
37. DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production.
Zhao X; Shen Y; Hu W; Chen J; Wu T; Sun X; Yu J; Wu T; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):641-7. PubMed ID: 26514427
[TBL] [Abstract][Full Text] [Related]
38. TRAIL is involved in CpG ODN-mediated anti-apoptotic signals.
Lim EJ; Park DW; Jeong TW; Chin BR; Bae YS; Baek SH
Oncol Rep; 2012 Apr; 27(4):1213-8. PubMed ID: 22159760
[TBL] [Abstract][Full Text] [Related]
39. An oligodeoxynucleotide with CCT repeats restrains CpG ODN-induced TLR9 trafficking.
Zhang X; Sun W; Wu X; Wang H; Yan Y; Guo S; Song D; Li H; Gao S; Wang L; Yu Y; Wang L
Curr Pharm Biotechnol; 2014; 15(9):780-9. PubMed ID: 25374030
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
Lim EJ; Lee SH; Lee JG; Kim JR; Yun SS; Baek SH; Lee C
Exp Mol Med; 2007 Apr; 39(2):239-45. PubMed ID: 17464186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
